Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients. [electronic resource]
- Multiple sclerosis (Houndmills, Basingstoke, England) Jun 1998
- 174-7 p. digital
Publication Type: Journal Article
1352-4585
10.1177/135245859800400316 doi
Adjuvants, Immunologic--therapeutic use Adolescent Adult Antigen-Antibody Reactions Biomarkers--blood HLA-DR Antigens--blood Humans Interferon beta-1a Interferon beta-1b Interferon-beta--therapeutic use Lymphocyte Activation Middle Aged Multiple Sclerosis--drug therapy Receptors, Interleukin-2--blood Recombinant Proteins--therapeutic use T-Lymphocytes--immunology